Search Results for "Medtronic Product Catalog Cardiology"

12:47 EST 22nd November 2014 | BioPortfolio

Matching Channels

Medtronic

With annual sales reaching $15 billion in 2010, Medtronic is the 4th largest medical devices company in the world (based on annual sales). The device portfolio of Medtronic is broad; covering card...

Boston Scientific

Boston Scientific is a global medical device company, the 8th largest (based on annual sales, which were over $8 billion in 2010). It is the world's second largest maker of heart devices; prod...

GE Healthcare

Ranked as the third largest medical device company in the world (based on annual sales), GE Healthcare generates $16 billion in sales each year. GEs' area of expertise is the imaging that is i...

The Top 10 Medical Device Companies

Medical devices are crucial to the process of diagnosis and treatment in modern medicine. Sales in this field reach billions of dollar a year, with Johnson & Johnson making $30 billion alone in ...

Tissue Growth Factors BMP 2

The classical tissue factors typically are proteins used for tissue repair and growth stimulation. Among the approved products are the growth factors PDGF, IGF, EGF, BMP and FGF. One of the commercial...

Matching News

Gas Analysis Catalog

Hiden Analytical has released its latest product catalog. The catalog highlights the full range of application-specific standard systems for analysis of gases and vapors in diverse environments, addre...

GOP Candidate Blames Medtronic’s Departure On Obamacare

Marty Seifert is a Republican running for Governor in Minnesota, where Minneapolis Medtronic is based — at least until Medtronic’s just-announced acquisition of Covidien closes, at which p...

Humana sues Medtronic over Infuse bone growth product

June 2 (Reuters) - Managed care company Humana Inc has filed a lawsuit against Medtronic Inc accusing the medical device maker of falsely representing its Infuse bone growth-stimulation product as saf...

Medtronic has entered into a M&A with Covidien

Medtronic and Covidien have entered into a definitive m&a agreement under which Medtronic has agreed to acquire Covidien in a cash-and-stock transaction valued at $93.22 per Covidien share, or a t...

BRIEF-Medtronic settles U.S. charges over alleged kickbacks to doctors

May 28 (Reuters) - Medtronic Inc : * U.S. says Medtronic Inc to pay $9.9 million to resolve claims under

Itamar signs pilot agreement with Medtronic for US WatchPAT rights

In a six-month pilot agreement, Itamar Medical Ltd. (diagnostic devices in cardiology and neurology areas) granted Medtronic Inc. US rights to sell its WatchPAT sleep diagnostic to patients with atria...

Medtronic in yet another M&A deal worth $350 million

Medtronic has completed the acquisition of NGC Medical in a m&a transaction that values NGC at $350 million. NGC will serve as the Managed Services arm for Medtronic’s Hospital Solutions bus...

Could Medtronic Have Better Spent $43 Billion?

By Paul Nouri, CFP:Medtronic (MDT), the largest independent med-tech company in the U.S., announced a deal to acquire Covidien (COV), a significant med-tech peer, for $93.22 per share, representing a ...

Matching PubMed Articles

Lower cardiovascular mortality with Medtronic CoreValve versus Edwards SAPIEN in patients with aortic valve stenosis undergoing transcatheter aortic valve implantation.

An integrated catalog of reference genes in the human gut microbiome.

Many analyses of the human gut microbiome depend on a catalog of reference genes. Existing catalogs for the human gut microbiome are based on samples from single cohorts or on reference genomes or pro...

A prospective, non-randomized comparison of SAPIEN XT and CoreValve implantation in two sequential cohorts of patients with severe aortic stenosis.

Few data is available comparing Edwards SAPIEN XT - SXT (Edwards Lifesciences, Irvine, California) with Medtronic CoreValve - CoV (Medtronic Inc., Minneapolis, Minnesota) in patients with severe aorti...

Lipid accumulation product and incident cardiovascular events in a normal weight population: Tehran Lipid and Glucose Study.

The lipid accumulation product (LAP) is a relatively new marker for measuring cardiovascular disease (CVD) risk factors. We investigated predictability of LAP value for incident CVD among Tehranian ad...

Launching a New Food Product or Dietary Supplement in the United States: Industrial, Regulatory, and Nutritional Considerations.

Launching a new food/dietary supplement into the US market can be a confusing process to those unfamiliar with the food industry. Industry capability and product specifications are initial determinant...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement